Sean Ong - Epworth HealthCare, EJ Whitten Fdn Prostate Canc Res Ctr, Richmond, Vic, Australia

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 74 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The CONFIRM Trial Protocol: the Utility of Prostate-Specific Membrane Antigen Positron Emission Tomography/computed Tomography in Active Surveillance for Prostate Cancer

Dominic Bagguley,Laurence Harewood,Dean McKenzie,Gideon Ptasznik,Sean Ong,Thilakavathi Chengodu,Dixon Woon,Kenneth Sim,James Sheldon,Nathan Lawrentschuk

BJU INTERNATIONAL (2024): 27-36

引用0浏览0WOS引用

First SARS-CoV-2 Omicron Infection As an Effective Immune Booster among Mrna Vaccinated Individuals: Final Results from the First Phase of the PRIBIVAC Randomised Clinical Trial

EBioMedicine (2024): 105275-105275

引用0浏览0WOS引用

Follow-up Blood Cultures Do Not Reduce Mortality in Hospitalized Patients with Gram-negative Bloodstream Infection: a Retrospective Population-Wide Cohort Study

Sean W. X. Ong,Jin Luo,Daniel J. Fridman,Samantha M. Lee,Jennie Johnstone,Kevin L. Schwartz,Christina Diong,Samir N. Patel,Derek MacFadden,Bradley Langford,Steven Y. C. Tong,Kevin A. Brown,Nick Daneman

Clinical Microbiology and Infection (2024)

引用0浏览0WOS引用

Epidemiology and Clinical Relevance of Persistent Bacteraemia in Patients with Gram-negative Bloodstream Infection: a Retrospective Cohort Study

Sean W. X. Ong,Jin Luo,Daniel J. Fridman,Samantha M. Lee,Jennie Johnstone,Kevin L. Schwartz,Christina Diong,Samir N. Patel,Derek R. Macfadden,Bradley J. Langford,Steven Y. C. Tong,Kevin A. Brown,Nick Daneman

Journal of Antimicrobial Chemotherapy（2024）

引用0浏览0WOS引用

Optilume® Drug-Coated Balloon May Lower the Re-Treatment Rate Postintervention for Challenging Urethral Stricture Disease in Long-Term Follow-Up: A Prospective Cohort Study

Zein Alhamdani,Sean Ong, Wenjie Zhong, Peter Chin

JOURNAL OF ENDOUROLOGYno. 11 (2024): 1192-1200

引用0浏览0WOS引用

Patient-centred Pathology Reporting Improves Patient Experience and Understanding of Disease in Prostate Cancer Care

Haidar Al Saffar,Alice Thomson,Jo-Lynn S. Tan, Qiwei Wang,Emma Birch,Samantha Koschel,Elizabeth Medhurst,Dale Jobson,Sean Ong,Daniel A. Moon,Declan Murphy,Nathan Lawrentschuk

BJUI COMPASS（2024）

引用0浏览0WOS引用

Choosing the Right Outcomes in Infectious Diseases Clinical Research-Putting Patients Front and Centre

Sean W. X. Ong,Devangi Patel, Sharon Reinblatt,Steven Y. C. Tong,Todd C. Lee,Emily G. McDonald,Nick Daneman

Clinical microbiology and infection（2024）

引用0浏览0WOS引用

First SARS-CoV-2 Omicron Infection As an Effective Immune Booster among Mrna Vaccinated Individuals: Fi Nal Results from the Fi Rst Phase of the PRIBIVAC Randomised Clinical Trial

Xuan Ying Poh,I. Russel Lee,Chee Wah Tan,Jean-Marc Chavatte,Siew Wai Fong,Yun Shan Goh,Angeline Rouers,Nathan Wong,Anthony Torres-Ruesta, Shirley Y. Y. Mah, Aileen Y. Y. Yeoh, Mihir Gandhi,Nabilah Rahman,Yi Qing Chin, J. Jonathan Lim, Terence J. K. Yoong,Suma Rao,Po Ying Chia,Sean W. X. Ong,Tau Hong Lee,Sapna P. Sadarangani,Ray J. H. Lin, Daniel R. X. Lim,Wanni Chia,Laurent Renia,Ee Chee Ren,Raymond T. P. Lin,David C. Lye,Lin-Fa Wang,Lisa F. P. Ng,Barnaby E. Young

EBIOMEDICINE (2024)

引用0浏览0引用

Immunogenicity of Mrna Vs. BBV152 Vaccine Boosters Against Omicron Subvariants: Final Results from Phase B of the PRIBIVAC Study, a Randomized Clinical Trial

Vaccineno. 25 (2024): 126275-126275

引用0浏览0WOS引用

Evaluating the Impact of a SIMPlified LaYered Consent Process on Recruitment of Potential Participants to the Staphylococcus Aureus Network Adaptive Platform Trial: Study Protocol for a Multicentre Pragmatic Nested Randomised Clinical Trial (SIMPLY-SNAP Trial)

Sean W. X. Ong,Todd C. Lee,Robert A. Fowler,Robert Mahar,Ruxandra L. Pinto,Asgar Rishu,Lina Petrella,Lyn Whiteway,Matthew Cheng,Emily Mcdonald,Jennie Johnstone,Dominik Mertz,Christopher Kandel,Ranjani Somayaji,Joshua S. Davis,Steven Y. C. Tong,Nick Daneman

BMJ Openno. 1 (2024): e083239-e083239

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn